Gilead Sciences, Inc. · NASDAQ:GILD

Dickinson Andrew D sold 3,000 Gilead Sciences, Inc. shares (Form 4)

Traded May 15, 2026 · Filed May 18, 2026

On May 15, 2026, Dickinson Andrew D (Chief Financial Officer) sold 3,000 Gilead Sciences, Inc. shares at US$132.27 for US$397K under a trading plan, leaving 173,191 shares. Filed May 18, 2026 (Form 4).

Sold: 3,000 shares
Price: US$132.27
Value: US$397K
Holding after: 173,191 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Financial Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
May 15, 2026	Common Stock	Sale	3,000	US$132.27	173,191	Direct

Source

View original at SEC

Related